Hilary Thomas

Assessment of Multidrug Resistance Reversal Using Dielectrophoresis and Flow Cytometry

Fatima H. Labeed, Helen M. Coley, Hilary Thomas et al. · Biophysical Journal · 2003 · 109 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +11

Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivity

Helen M. Coley, Fatima H. Labeed, Hilary Thomas et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2006 · 95 citations

Medicine, Oncology, Pharmacology +13

A Multicenter Phase I Gene Therapy Clinical Trial Involving Intraperitoneal Administration of E1A-Lipid Complex in Patients with Recurrent Epithelial Ovarian Cancer Overexpressing HER-2/<b> <i>neu</i> </b> Oncogene

Srinivasan Madhusudan, Ayala Tamir, Nicholas P Bates et al. · Clinical Cancer Research · 2004 · 69 citations

Medicine, Oncology, Pharmacology +16

Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer

Matthew Cunningham, Sharadah Essapen, Hilary Thomas et al. · International Journal of Oncology · 2005 · 68 citations

Medicine, Oncology, Pathology +17

Targeting of cells expressing wild‐type EGFR and type‐III mutant EGFR (EGFRvIII) by anti‐EGFR MAb ICR62: A two‐pronged attack for tumour therapy

Helmout Modjtahedi, David K. Moscatello, Gary Box et al. · International Journal of Cancer · 2003 · 60 citations · Full text

Medicine, Oncology, Pharmacology +16